Integra Lifesciences Holdings Corp (IART) volume hits 1.68 million: A New Opening for Investors

Integra Lifesciences Holdings Corp (NASDAQ: IART) flaunted slowness of -0.68% at $17.60, before settling in for the price of $17.72 at the close. Taking a more long-term approach, IART posted a 52-week range of $17.56-$45.42.

It was noted that the giant of the Healthcare sector posted annual sales growth of 1.17% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 3.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -20.99%. This publicly-traded company’s shares outstanding now amounts to $78.17 million, simultaneously with a float of $65.06 million. The organization now has a market capitalization sitting at $1.37 billion. At the time of writing, stock’s 50-day Moving Average stood at $24.53, while the 200-day Moving Average is $33.05.

Integra Lifesciences Holdings Corp (IART) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Integra Lifesciences Holdings Corp industry. Integra Lifesciences Holdings Corp’s current insider ownership accounts for 16.14%, in contrast to 90.63% institutional ownership. According to the most recent insider trade that took place on Aug 19 ’24, this organization’s SVP, Fin & Princ Acct Officer sold 1,191 shares at the rate of 21.58, making the entire transaction reach 25,701 in total value, affecting insider ownership by 36,088. Preceding that transaction, on May 23 ’24, Company’s Exec. Chairman of the Board bought 52,641 for 28.49, making the whole transaction’s value amount to 1,499,979. This particular insider is now the holder of 487,922 in total.

Integra Lifesciences Holdings Corp (IART) Earnings and Revenue Records

Integra Lifesciences Holdings Corp’s EPS decrease for this current 12-month fiscal period is -20.99% and is forecasted to reach 2.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.30% through the next 5 years, which can be compared against the 3.10% growth it accomplished over the previous five years trading on the market.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators

Let’s observe the current performance indicators for Integra Lifesciences Holdings Corp (IART). It’s Quick Ratio in the last reported quarter now stands at 2.10. The Stock has managed to achieve an average true range (ATR) of 0.85. Alongside those numbers, its PE Ratio stands at $59.64, and its Beta score is 1.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.87. Similarly, its price to free cash flow for trailing twelve months is now 23.19.

In the same vein, IART’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.30, a figure that is expected to reach 0.39 in the next quarter, and analysts are predicting that it will be 2.51 at the market close of one year from today.

Technical Analysis of Integra Lifesciences Holdings Corp (IART)

Now, what If we examine the latest scores posted by [Integra Lifesciences Holdings Corp, IART]. During the last 5-days, its volume was better the volume of 1.13 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 6.99% While, its Average True Range was 0.79.

Raw Stochastic average of Integra Lifesciences Holdings Corp (IART) in the period of the previous 100 days is set at 4.08%, which indicates a major fall in contrast to 14.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 37.50% that was lower than 62.03% volatility it exhibited in the past 100-days period.